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OBJECTIVES The aim of this study was to determine whether noncontact mapping is feasible in the right
ventricle and assess its utility in guiding ablation of difficult-to-treat right ventricular outflow
tract (RVOT) ventricular tachycardia (VT).
BACKGROUND In patients without inducible arrhythmia, RVOT VT may be difficult to ablate. Noncontact
mapping permits ablation guided by a single tachycardia complex, which may facilitate
ablation of difficult cases. However, the mapping system may be geometry-dependent, and it
has not been validated in the unique geometry of the RVOT.
METHODS Ten patients with left bundle inferior axis VT, no history of myocardial infarction and normal
left ventricular function underwent noncontact guided ablation; seven had failed previous
ablation and three had received a defibrillator. All noncontact maps were analyzed by a
blinded reviewer to determine whether the arrhythmia focus was epicardial and to predict on
the basis of the map whether arrhythmia would recur.
RESULTS The procedure was acutely successful in 9 of 10 patients. During a mean follow-up of 11
months, 7 of 9 patients remained arrhythmia-free. Both patients in whom the blinded
reviewer predicted failure had arrhythmia recurrence: one due to epicardial origin with
multiple endocardial exit sites and one due to discordance between site of lesion placement
and earliest activation on noncontact map.
CONCLUSIONS Mechanisms of ablation failure in RVOT VT include absence of sustained arrhythmia,
difficulty with substrate localization and epicardial origin of arrhythmia. In this study,
noncontact mapping was safely and effectively used to guide ablation of patients with
difficult-to-treat RVOT VT. (J Am Coll Cardiol 2002;39:1808–12) © 2002 by the
American College of Cardiology Foundation
In patients with left bundle inferior axis ventricular tachy-
cardia (VT) and a structurally normal heart, arrhythmia
usually arises from abnormal triggered activity in the right
ventricular outflow tract (RVOT). Radiofrequency (RF)
catheter ablation can eliminate tachycardia in 83% to 100%
of patients (1). In some patients with clinically problematic
arrhythmia and failed ablation, absence of VT or clinical
ectopy despite adrenergic and electrical stimulation in the
electrophysiology laboratory limits localization of the ar-
rhythmogenic substrate. Recently, a noncontact mapping
system capable of recording endocardial potentials from
3,000 sites simultaneously to create a three-dimensional
(3-D) map of electrical activation has been introduced into
clinical practice (2–5). This system permits generation of a
potential map from a single premature ventricular complex
and may help guide difficult ablation procedures. Noncon-
tact mapping has been validated in the right atrium and left
ventricle and approved for use in the U.S. in the right atrium
alone. Whether it can be used in the unique geometry of the
right ventricle (RV) has not been established. We sought to
determine whether this new mapping system could be
employed in the RV to guide ablation in patients with
difficult-to-ablate RVOT VT. Additionally, due to the
high-density data acquisition afforded by noncontact map-
ping, we sought to characterize the mechanism of proce-
dural failure in those patients in whom ablation was unsuc-
cessful.
METHODS
Patient characteristics. Between July 1999 and October
2000, 10 patients with left bundle inferior axis VT, no
history of myocardial infarction and a normal left ventricular
ejection fraction were referred to our laboratory for catheter
ablation and underwent noncontact mapping. Patients had
a history of VT for 5.4  5.5 years and had failed 3  1
antiarrhythmic medications. In all patients, echocardiogra-
phy demonstrated normal left ventricular function. Seven
patients had previously undergone unsuccessful ablation
elsewhere. Pace mapping was used to guide previous abla-
tion in four patients and not used in one; information
regarding pace mapping was not available in two patients.
Three patients with fast or syncopal VT and unsuccessful
previous ablation had received an implantable defibrillator
before referral; one of these patients had magnetic resonance
imaging abnormalities suggestive of arrhythmogenic RV
dysplasia (Table 1). In one patient without an implantable
cardioverter defibrillator (ICD) at the time of noncontact
ablation, nondiagnostic RV abnormalities were noted on
computed tomography scan.
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Electrophsyiology and mapping study. Programmed
stimulation was performed with up to three extrastimuli
from two RV sites. The following pharmacologic stimula-
tion was used in an effort to induce VT: isoproterenol (all
patients), epinephrine (four patients), aminophylline (two
patients), adenosine (one patient), atropine (one patient)
and phenylephrine (one patient).
The details of the Ensite 3000 mapping system (Endo-
cardial Solutions, Saint Paul, Minnesota) have been previ-
ously described (2). The system utilizes a noncontact map-
ping catheter that contains 64 filaments with 0.025-in
insulation breaks at specified sites to form a multielectrode
array. This array was advanced through the vasculature in
low profile to the RVOT over a guide wire. A standard
deflectable 4- or 5-mm tip ablation catheter was then placed
in the pulmonary artery and slowly withdrawn until sharp
bipolar electrograms were recorded on the distal electrodes,
signifying the pulmonary valve-RVOT junction. Using this
position as a fluoroscopic landmark, the noncontact array
was then deployed at least 1 cm below the valve (Fig. 1).
With the multiple electrode array (MEA) in position, a
geometry of the RV was created. The location of the
mapping catheter relative to the MEA was determined by
the system using a low-current “locator” signal. Location
positions were automatically acquired 10 times per second.
With each passage of the mapping catheter to a new, more
distant location from the MEA, the position was taken as
the endocardial boundary. Sweeping a mapping catheter
along the RV endocardium resulted in 3-D chamber geom-
etry. Care was taken to create a high-density RVOT
geometry and to “tag” at least two points at the junction of
the RVOT and pulmonary valve, as well as points at the RV
apex and His bundle positions.
Upon geometry completion, global RV potential voltage
maps from a single premature ventricular complex could be
created. These were displayed on the computer workstation
as a 3-D endocardial potential map that changed in time as
the computer-generated “movie” of cardiac activation ad-
vanced. In all patients, 12-lead electrocardiograms (ECG)
of any RVOT ectopy, nonsustained VT or sustained VT
were reviewed to ensure a morphology identical to the
clinical tachycardia. When the morphology of the recorded
complexes matched the clinical arrhythmia, isopotential
maps were generated to identify the earliest site of activa-
tion. Virtual electrograms were reconstructed at sites of
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earliest activation on the isopotential maps to look for a
unipolar QS pattern (Fig. 2). Once earliest activation was
identified, the site was labeled on the 3-D map and the
locator signal used to navigate the ablation catheter to it in
real time during normal rhythm when sustained tachycardia
was not inducible.
A blinded reviewer (S. J. A.) who did not participate in
any of the electrophysiologic procedures analyzed all non-
contact maps to determine whether the arrhythmia focus
was epicardial and to predict whether arrhythmia would
recur. A focus was defined as epicardial if virtual electro-
grams at the earliest activation site had an R-wave (as
opposed to a QS pattern) and the color map at this site had
a broad (as opposed to discrete, focal) appearance. Compar-
ison of the arrhythmia potential map with the labeled
ablation sites (tagged on the geometry) was used to predict
success.
All noncontact studies were performed with a specially
trained nurse operating the noncontact computer system
under the direction of the attending electrophysiologist and
in the absence of representatives from the manufacturer of
the mapping system.
Follow-up. All patients were seen in the clinic or contacted
by telephone to determine clinical status. Patients with
symptoms suggestive of arrhythmia recurrence were further
assessed by ECG, event recorder or Holter monitoring.
Patients with implantable defibrillators underwent device
interrogation.
RESULTS
The noncontact mapping system was successfully deployed
in the RVOT in all 10 consecutive patients. Deployment of
the MEA catheter in the RVOT required 14  9 min
Figure 1. Fluoroscopic image of the noncontact array in the right ventric-
ular outflow tract.
Figure 2. Isopotential map of right ventricular outflow tract (RVOT) activation (left) and virtual electrograms at the site of earliest activation (note QS
pattern).
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(range 6 to 30 min), and geometry creation took 23 
11 min (range 11 to 41 min). In 5 of 10 patients, only
isolated ectopy or transient arrhythmia was present at the
time of noncontact study. No patient had electrocardio-
graphic characteristics suggestive of left ventricular or sinus
of Valsalva arrhythmia origin (6–8). Isopotential movies
demonstrated point-source ectopy in all patients; re-entry
was not seen as the cause of arrhythmia in any of the
patients. Noncontact guided ablation was acutely successful
in 9 of 10 patients. The one patient with acute procedural
failure had no further ectopy after deployment of the MEA
so that no RF energy was delivered. Earliest activation sites
were anteroseptal (n  5), posteroseptal (n  4) and
midseptal (n  1) RVOT. One patient had two different
early sites (anteroseptal and posteroseptal), and both were
ablated. In one patient with frequent ectopy, the noncontact
system failed to identify the ultimately successful ablation
site. In that patient, activation time mapping of the ectopy,
assisted by the noncontact locator system, resulted in suc-
cessful ablation. The average number of RF energy deliver-
ies until success was achieved (no further ectopy or VT) was
3.7  2.6. There were no complications.
During a mean follow-up of 11  6 months, 7 of the 9
ablated patients (77.5%, 95% confidence intervals: 46.5% to
100%) remained free of arrhythmia recurrence, 6 in the
absence of antiarrhythmic drugs. One patient with an
implantable defibrillator was treated with propafenone;
device interrogation and electrogram analysis after an ICD
shock revealed a supraventricular arrhythmia. Of the four
patients with no inducible arrhythmia at noncontact study
who underwent ablation, two had arrhythmia recurrence
during long-term follow-up (Table 1).
The blinded reviewer predicted procedural failure in two
patients; both had recurrent arrhythmia. In one patient
(Patient 4 in Table 1), ablation lesions were placed at a site
removed from the earliest activation on the noncontact map
as determined by review. In the second patient (Patient 8),
the earliest activation was from an epicardial focus, which
then propagated along two discrete pathways with subse-
quent breakout at two endocardial sites. Ablation had been
directed at both endocardial sites.
DISCUSSION
Main findings. We found noncontact mapping to be a
useful adjunct to guiding ablation in a consecutive series of
patients with RVOT VT. This patient population reflected
a particularly challenging ablation group: 70% of patients
had failed previous ablation, 30% of patients had received
ICD therapy before referral and 50% had no sustained VT
to guide mapping. Despite this, noncontact-guided ablation
was acutely successful in 90% of this population, with no
recurrence in 78% of acutely successful patients during a
mean follow-up of 11 months.
Mechanism of failure in RVOT VT ablation. Although
catheter ablation has proven highly effective for most
patients with RVOT VT, there are several mechanisms that
may account for procedure failure. In the absence of
inducible arrhythmia or frequent ectopy, pace mapping has
been used to guide ablation. Wen et al. (9) found that use of
pace mapping alone for ablation site selection was a predic-
tor of tachycardia recurrence in patients with idiopathic
RVOT VT. Pace mapping may be limited by anodal
capture, by capture of a large region of myocardium or by
similar appearing pace maps obtainable with stimulation
from a relatively large region of myocardium. The resolution
of pace mapping is approximately 5 mm to 10 mm, even
with the use of strict criteria (10). This may be a limiting
factor because typical RF lesions are 5 mm in diameter (11).
Additionally, pacing rate differences as small as 80 ms from
the coupling interval of spontaneous ectopy or from the VT
cycle length result in rate-dependent changes in QRS
morphology that can be confounded with site-dependent
morphology changes (10). The difficulty in ablating RVOT
VT in the absence of sustained arrhythmia is supported by
the present study. In five of the seven patients with previous
failed ablation, failure was attributed to a transient or
noninducible arrhythmia. Our long-term success in seven of
nine patients based on mapping spontaneous arrhythmia
activity (as opposed to pace mapping) supports the useful-
ness of defining the site of spontaneous activity.
Given the relatively small size of RF lesions, precise
substrate localization and placement of the ablation catheter
immediately adjacent to the arrhythmogenic tissue may be
critical for successful ablation. Factors associated with failed
ablation include a delta wave-like QRS onset (suggesting
epicardial origin) and short endocardial activation to QRS
onset times, both suggesting distance between ablation
catheter and target (9). Indeed, one of the two patients with
arrhythmia recurrence in the present study had noncontact
map characteristics suggesting an epicardial arrhythmia
origin upon blinded review. The use of high-density isopo-
tential maps and unipolar virtual electrograms may have
improved target localization and led to successful ablation in
the absence of frequent ectopy or sustained VT. In the
thin-walled RVOT, it is conceivable that precise catheter
positioning may permit endocardial RF treatment of some
epicardial foci. Previous reports have described abnormal
triggered activity as the mechanism for RVOT VT (12).
Our observations corroborate this, in that all VTs had a
focal origin documented with high-density global chamber
maps.
Use of noncontact mapping in the RVOT. Use of non-
contact mapping in the RVOT has not been previously
reported. Theoretical limitations include mechanical ob-
struction of the pulmonic valve and mapping limitations due
to the odd-shaped RV chamber geometry. We were able to
deploy the MEA and create geometries in all patients
without complication. However, one patient had no further
ectopy after MEA deployment, possibly due to inadvertent
“bumping” of the focus during deployment. Additionally, in
another patient, the noncontact map failed to identify the
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appropriate target. This may have stemmed from inadver-
tent MEA contact with the RVOT and contact ectopy or
from difficulty interpreting the noncontact map using an
early version of the system software. Despite these limita-
tions, the system was successfully employed in 80% of
patients.
Study limitations. Pace mapping has been used to guide
ablation in the absence of inducible arrhythmia. We did not
randomize patients to pace mapping versus noncontact
mapping to determine which technique is superior. How-
ever, pace mapping was used to guide the initial ablation in
at least four of the seven patients with previous failed
ablation. Pace mapping was performed in 7 of 10 patients
after noncontact mapping, at the site predicted by the
noncontact map. It demonstrated a 12 of 12 match in all but
2 patients (both with 11 of 12 match), both of whom had
late arrhythmia recurrence. Because the noncontact map
locator signal may facilitate pace mapping (by cataloging
points at which maps are performed and redirecting the
catheter to promising sites), these techniques may be com-
plementary. The small size of our study limits the strength
of our conclusions.
Conclusions. In conclusion, mechanisms of ablation fail-
ure in RVOT VT include absence of sustained arrhythmia,
difficulty with substrate localization and epicardial origin of
arrhythmia. In this study, noncontact mapping was safely
and effectively used to guide ablation of patients with
difficult-to-treat RVOT VT.
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